OBI Pharma, Inc. announced the change of internal audit officer. Name, title, and resume of the previous position holder: Neo Chien/Director /Internal audit director, OBI Pharma Inc. Name, title, and resume of the new position holder: Hanna Hsu/Supervisor /Internal audit supervisor, OBI Pharma Inc. Reason for the change: Position adjustment. Effective date: November 6, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
61.3 TWD | +0.16% | +0.49% | -11.67% |
1st Jan change | Capi. | |
---|---|---|
-11.67% | 433M | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- 4174 Stock
- News OBI Pharma, Inc.
- OBI Pharma, Inc. Announces Internal Audit Officer Changes